Scarica l'app Stockscreener
36.61
4.98%
-1.92
Dopo l'orario di chiusura:
36.51
-0.10
-0.27%
Precedente Chiudi:
$38.53
Aprire:
$38.06
Volume 24 ore:
1.94M
Relative Volume:
1.37
Capitalizzazione di mercato:
$1.32B
Reddito:
$117.67M
Utile/perdita netta:
$-1.88B
Rapporto P/E:
-0.6048
EPS:
-60.5369
Flusso di cassa netto:
$-621.36M
1 W Prestazione:
-13.10%
1M Prestazione:
-13.90%
6M Prestazione:
+110.34%
1 anno Prestazione:
+88.23%
Intervallo 1D:
$34.50
$38.69
Intervallo di 1 settimana:
$34.50
$44.30
Portata 52W:
$12.33
$63.99
Grail Inc Stock (GRAL) Company Profile
Nome
Grail Inc
Settore
Industria
Telefono
(833) 694-2553
Indirizzo
1525 O'BRIEN DRIVE, MENLO PARK
Confronta GRAL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GRAL
Grail Inc
|
36.61 | 1.52B | 117.67M | -1.88B | -621.36M | -60.54 |
|
TMO
Thermo Fisher Scientific Inc
|
416.31 | 158.50B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
193.30 | 143.82B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
520.57 | 43.48B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
113.43 | 34.46B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
158.64 | 28.03B | 15.50B | 1.33B | 2.16B | 7.34 |
Grail Inc Stock (GRAL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-21 | Iniziato | Canaccord Genuity | Buy |
| 2024-11-27 | Iniziato | Morgan Stanley | Equal-Weight |
| 2024-11-15 | Iniziato | Wolfe Research | Peer Perform |
| 2024-10-17 | Iniziato | Guggenheim | Neutral |
Grail Inc Borsa (GRAL) Ultime notizie
GRAIL’s Galleri Multi-Cancer Test Shows Strong Performance in PATHFINDER 2 Study, Paves Way for FDA Submission - Insider Monkey
Illumina: A Compelling Buy Despite GRAIL Divestiture and Macroeconomic Challenges - AInvest
Illumina: Higher Profit Margin Despite GRAIL Divestiture And Macroeconomic Headwinds - Seeking Alpha
Grail (GRAL) PT Hiked to $38 at Morgan Stanley amid ‘Equal Weight’ Stance - MSN
Grail (GRAL): A High-Reward, High-Risk Play on Cancer Detection's Future - AInvest
15 Successful Spin-Off Companies and Their 2025 Returns - Insider Monkey
GRAIL Insiders Selling US$10m In Stock Relieved As Market Cap Slides To US$1.7b - simplywall.st
GRAIL's Insider Sales: Red Flag or Strategic Move? Assessing Executive Confidence Amid Strong Financials - AInvest
GRAIL, Inc.(NasdaqGS: GRAL) added to Russell 2500 Value Index - MarketScreener
GRAIL, Inc.'s Russell 2500 Inclusion: A Catalyst for Institutional Capital and Liquidity Gains - AInvest
Morgan Stanley raises Grail stock price target to $38 on cancer test potential - Investing.com
Grail plans FDA filing for cancer blood test after new trial - pharmaphorum
Grail reports positive outcomes from registrational study of Galleri test - Yahoo
Grail plans to submit updated Galleri blood test for FDA approval next year - Fierce Biotech
Grail stock gains on new data for Galleri cancer test (GRAL) - Seeking Alpha
GRAIL reports positive results from cancer detection test study By Investing.com - Investing.com Nigeria
GRAIL reports positive results from cancer detection test study - Investing.com Australia
GRAIL Announces Positive Top-Line Results From The Galleri PATHFINDER 2 Registrational Study - MarketScreener
Grail reports results from PATHFINDER 2 study - TipRanks
Revolutionary Cancer Screening Test Achieves Major Clinical Success: GRAIL's Galleri Outperforms Previous Study - Stock Titan
GRAIL: Too Much A Leap Of Faith (NASDAQ:GRAL) - Seeking Alpha
California State Teachers Retirement System Takes $464,000 Position in Grail, Inc. (NASDAQ:GRAL) - Defense World
67,288 Shares in Grail, Inc. (NASDAQ:GRAL) Acquired by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World
NINGI short Grail, says ‘approval and commercialization all but impossible’ - TipRanks
GRAIL stock tumbles on short-seller report By Investing.com - Investing.com Nigeria
GRAIL stock tumbles on short-seller report - Investing.com
Ningi Research Says Short Grail - marketscreener.com
3 Medical Technology Stocks Outperforming in 2025 - inkl
GRALGRAIL Reports First Quarter 2025 Financial Results - mx.advfn.com
Wellington Management Group LLP Takes Position in Grail, Inc. (NASDAQ:GRAL) - Defense World
Two Sigma Advisers LP Makes New $345,000 Investment in Grail, Inc. (NASDAQ:GRAL) - Defense World
For FMCG Inc., the holy grail of volume growth is in sight | Company Business News - Mint
Nuveen Asset Management LLC Takes $837,000 Position in Grail, Inc. (NASDAQ:GRAL) - Defense World
Transcript : GRAIL, Inc. Presents at Jefferies Global Healthcare Conference 2025, Jun-04-2025 11 - marketscreener.com
BNP Paribas Financial Markets Invests $50,000 in Grail, Inc. (NASDAQ:GRAL) - Defense World
Ameriprise Financial Inc. Takes $681,000 Position in Grail, Inc. (NASDAQ:GRAL) - Defense World
GRAIL, Inc. (GRAL) Stock Analysis: Evaluating the 19.10% Revenue Growth Against Market Challenges - DirectorsTalk Interviews
96,630 Shares in Grail, Inc. (NASDAQ:GRAL) Purchased by Two Sigma Investments LP - Defense World
GRAIL announces inducement grants - Medical Buyer
Grail Inc. stockholders elect director, ratify auditor By Investing.com - Investing.com Nigeria
Grail Inc. stockholders elect director, ratify auditor - Investing.com
GRAIL Inc Holds Annual Stockholders Meeting - TipRanks
GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - PR Newswire
Grail (GRAL) and Its Competitors Head-To-Head Analysis - Defense World
Rêve Health to Offer GRAIL’s Galleri® Multi-Cancer Early Detection Test - Fitt Insider
Millennium Management LLC Takes $5.28 Million Position in Grail, Inc. (NASDAQ:GRAL) - Defense World
(GRAL) Technical Data - news.stocktradersdaily.com
Man Group plc Buys New Position in Grail, Inc. (NASDAQ:GRAL) - Defense World
56,062 Shares in Grail, Inc. (NASDAQ:GRAL) Bought by Deutsche Bank AG - Defense World
145,949 Shares in Grail, Inc. (NASDAQ:GRAL) Purchased by Northern Trust Corp - Defense World
Janus Henderson Group PLC Invests $223,000 in Grail, Inc. (NASDAQ:GRAL) - Defense World
Grail Inc Azioni (GRAL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Grail Inc Azioni (GRAL) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| DING CHUN R | 10% Owner |
Jul 01 '25 |
Sale |
49.53 |
339,800 |
16,830,151 |
3,305,055 |
| Ofman Joshua J. | President |
Jun 30 '25 |
Sale |
52.00 |
9,692 |
503,984 |
492,076 |
0.00%
0.97%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):